NACELLE THERAPEUTICS, INC.

Basic Information

NACELLE THERAPEUTICS, INC.
1500 HAYES DR
MANHATTAN, KS, 66502

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Enhanced Drug Access to Eye Tissues

    Amount: $232,945.00

    DESCRIPTION (provided by applicant) The innovative use of a synthetic peptide to modulate epithelial cell-cell interactions is proposed for the augmentation of drug- or gene-based therapeutic interven ...

    SBIR Phase I 2004 Department of Health and Human Services
  2. CHANNEL REPLACEMENT THERAPY FOR CYSTIC FIBROSIS

    Amount: $195,000.00

    Nacelle's overall objective is to develop and commercialize a superior cystic fibrosis (CF) therapeutic, derived from a family of unique peptides that will form functional ion channels in defective ce ...

    SBIR Phase I 2002 Department of Health and Human Services
  3. SYNTHETIC PEPTIDE MODULATORS OF PARACELLULAR CONDUCTANCE

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The innovative use of a synthetic peptide to modulate epithelial or endothelial cell-cell interactions is proposed for the augmentation of drug- or gene-based the ...

    SBIR Phase I 2002 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government